CRSP icon

CRISPR Therapeutics

433 hedge funds and large institutions have $3.28B invested in CRISPR Therapeutics in 2022 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 124 increasing their positions, 122 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
433
Holders Change
-11
Holders Change %
-2.48%
% of All Funds
7.32%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
59
Increased
124
Reduced
122
Closed
62
Calls
$193M
Puts
$182M
Net Calls
+$10.4M
Net Calls Change
+$17.4M
Name Holding Trade Value Shares
Change
Shares
Change %
ED
401
Exane Derivatives
France
$1.22K
CP
402
Corbenic Partners
Pennsylvania
$1K -$2K -40 -67%
CFD
403
Creative Financial Designs
Indiana
$1K
DSC
404
Duncker Streett & Co
Missouri
$1K
CFFP
405
Center for Financial Planning
Michigan
$1K
NSIM
406
North Star Investment Management
Illinois
$1K
MIM
407
Macroview Investment Management
Maryland
$1K
FWA
408
FSC Wealth Advisors
New York
$1K
CFB
409
Cullen/Frost Bankers
Texas
$1K
JWM
410
Janiczek Wealth Management
Colorado
$1K
HS
411
Horan Securities
United States
$1K
IFAM
412
Institutional & Family Asset Management
Colorado
$1K
FPS
413
Fieldpoint Private Securities
Connecticut
$1K
TFS
414
TrustCore Financial Services
Tennessee
$1K
KFI
415
Key Financial Inc
Pennsylvania
$1K
TFM
416
TFC Financial Management
Massachusetts
$1K
CSB
417
City State Bank
Iowa
$1K
GCS
418
Gordian Capital (Singapore)
Singapore
$1K +$1K +1 New
BIA
419
Bell Investment Advisors
California
$1K +$1K +9 New
CI
420
CX Institutional
Indiana
$1K +$1K +10 New
EWA
421
EverSource Wealth Advisors
Alabama
$1K +$1K +15 New
NMG
422
New Millennium Group
Utah
$1K +$1K +16 New
SWA
423
SOA Wealth Advisors
New York
$1K +$1K +18 New
CFN
424
Cordasco Financial Network
Florida
$1K +$1K +20 New
CCM
425
Chilton Capital Management
Texas
$1K +$1K +20 New